Skip to main content
. Author manuscript; available in PMC: 2024 Apr 9.
Published in final edited form as: Hypertension. 2017 May 8;70(1):50–58. doi: 10.1161/HYPERTENSIONAHA.117.09188

Table 6.

Prevalence Rates of Ambulatory Hypertension After Exclusion of Subjects With Risk Factors

Participants Free of
Cohort All Participants Smoking Diabetes Mellitus Obesity Cholesterol ≥6.2 mmol/L History of CVD All Risk Factors
Copenhagen 1045/2142 (48.8) 629/1208 (52.1) 992/2069 (47.9) 812/1812 (44.8) 501/1128 (44.4) 953/2013 (47.3) 201/489 (41.1)
Ohasama 609/1275 (47.8) 487/1042 (46.7) 487/1052 (46.3) 588/1243 (47.3) 550/1175 (46.8) 552/1209 (45.7) 325/760 (42.8)
Noorderkempen 332/943 (35.2) 252/678 (37.2) 303/906 (33.4) 238/791 (30.1) 194/608 (31.9) 258/835 (30.9) 74/321 (23.1)
Montevideo 471/962 (49.0) 390/769 (50.7) 422/887 (47.6) 316/717 (44.1) 298/604 (49.3) 424/881 (48.1) 140/321 (43.6)
JingNing 111/189 (58.7) 77/128 (60.2) 111/189 (58.7) 107/185 (57.8) 96/170 (56.5) 103/181 (56.9) 56/103 (54.4)
EPOGH 259/491 (52.7) 200/373 (53.6) 229/453 (50.6) 169/353 (47.9) 176/341 (51.6) 202/407 (49.6) 59/144 (41.0)
Maracaibo 362/544 (66.5) 309/457 (67.6) 253/410 (61.7) 253/394 (64.2) 286/436 (65.6) 308/480 (64.2) 108/184 (58.7)
All 3189/6546 (48.7) 2344/4655 (50.4) 2797/5966 (46.9) 2483/5495 (45.2) 2101/4462 (47.1) 2800/6006 (46.6) 963/2322 (41.5)

Values are the number of hypertensive participants and the total number of participants not having the corresponding risk factor. The number between brackets is the percentage hypertensive subjects. Diabetes mellitus was the use of antidiabetic drugs, a fasting glucose ≥7.0 mmol/L, a random glucose ≥11.1 mmol/L, a self-reported diagnosis, or diabetes mellitus documented in practice or hospital records. Obesity was a body mass index ≥30 kg/m2. CVD indicates cardiovascular disease; and EPOGH, European Project on Genes in Hypertension.